WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000024417) A METHOD OF REGULATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/024417    International Application No.:    PCT/AU1999/000915
Publication Date: 04.05.2000 International Filing Date: 22.10.1999
Chapter 2 Demand Filed:    23.05.2000    
IPC:
A61K 38/17 (2006.01), A61K 38/21 (2006.01), G01N 33/50 (2006.01), G01N 33/68 (2006.01)
Applicants: MONASH UNIVERSITY [AU/AU]; Wellington Road, Clayton, VIC 3168 (AU) (For All Designated States Except US).
HERTZOG, Paul, John [AU/AU]; (AU) (For US Only).
HARDY, Matthew, Philip [AU/AU]; (AU) (For US Only).
OWCZAREK, Catherine, Mary [NZ/AU]; (AU) (For US Only).
KOLA, Ismail [AU/AU]; (AU) (For US Only)
Inventors: HERTZOG, Paul, John; (AU).
HARDY, Matthew, Philip; (AU).
OWCZAREK, Catherine, Mary; (AU).
KOLA, Ismail; (AU)
Agent: SLATTERY, John, M; Davies Collison Dave, 1 Little Collins Street, Melbourne, VIC 3000 (AU)
Priority Data:
PP 6706 23.10.1998 AU
Title (EN) A METHOD OF REGULATION
(FR) METHODE DE REGULATION
Abstract: front page image
(EN)The present invention relates generally to a method of regulating interferon functional activity and agents used for the same. More particularly, the present invention contemplates a method of regulating the functional activity of type I interferon by administering a soluble type I interferon receptor, and still more particularly IFNAR 2a. The method of the present invention is useful, $i(inter alia), in a range of therapeutic and prophylactic applications.
(FR)La présente invention concerne, de manière générale, une méthode permettant de réguler l'activité fonctionnelle de certains interférons, ainsi que les agents utilisés à cet effet. En particulier, la présente invention concerne une méthode de régulation de l'activité fonctionnelle de l'interféron de type I, qui consiste à administrer un récepteur soluble de l'interféron de type I, plus précisément IFNAR 2a. La méthode selon la présente invention est utile, entre autres, dans le cadre de diverses applications thérapeutiques et prophylactiques.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)